In last trading session, Virios Therapeutics Inc (NASDAQ:VIRI) saw 5.91 million shares changing hands with its beta currently measuring 1.79. Company’s recent per share price level of $0.46 trading at $0.13 or 37.90% at ring of the bell on the day assigns it a market valuation of $8.81M. That closing price of VIRI’s stock is at a discount of -426.09% from its 52-week high price of $2.42 and is indicating a premium of 39.13% from its 52-week low price of $0.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.17 million shares which gives us an average trading volume of 260.16K if we extend that period to 3-months.
Virios Therapeutics Inc (NASDAQ:VIRI) trade information
Upright in the green during last session for gaining 37.90%, in the last five days VIRI remained trading in the green while hitting it’s week-highest on Friday, 03/22/24 when the stock touched $0.46 price level, adding 26.84% to its value on the day. Virios Therapeutics Inc’s shares saw a change of -20.45% in year-to-date performance and have moved 43.84% in past 5-day. Virios Therapeutics Inc (NASDAQ:VIRI) showed a performance of 16.15% in past 30-days. Number of shares sold short was 96200.0 shares which calculate 0.68 days to cover the short interests.
Virios Therapeutics Inc (VIRI) estimates and forecasts
Statistics highlight that Virios Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -51.34% of value to its shares in past 6 months, showing an annual growth rate of 3.57% while that of industry is 12.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to increase by 50.00% in the current quarter and calculating 50.00% increase in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.02% during past 5 years.
VIRI Dividends
Virios Therapeutics Inc is more likely to be releasing its next quarterly report on February 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Virios Therapeutics Inc (NASDAQ:VIRI)’s Major holders
Insiders are in possession of 9.71% of company’s total shares while institution are holding 8.12 percent of that, with stock having share float percentage of 8.99%. Investors also watch the number of corporate investors in a company very closely, which is 8.12% institutions for Virios Therapeutics Inc that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at VIRI for having 0.21 million shares of worth $95543.0. And as of Dec 30, 2023, it was holding 1.08% of the company’s outstanding shares.
The second largest institutional holder is Renaissance Technologies, LLC, which was holding about 0.21 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 1.07% of outstanding shares, having a total worth of $94543.0.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 0.21 million shares of worth $95543.0 or 1.08% of the total outstanding shares. The later fund manager was in possession of 93131.0 shares on Jan 30, 2024, making its stake of worth around $42598.0 in the company or a holder of 0.48% of company’s stock.
